Literature DB >> 7241024

Multiple sclerosis in the Orkney and Shetland Islands. IV: Viral antibody titres and viral infections.

D C Poskanzer, J L Sever, J L Sheridan, L B Prenney.   

Abstract

A controlled serologic survey of antibody titres to 17 viruses was undertaken in multiple sclerosis patients in the Orkney and Shetland Islands. No consistent pattern of elevated antibody titre levels or the presence of antibody was noted in patients compared with two control groups. Because of the isolation of these islands, the mean age at acquisition of common childhood infections, including measles, was considerably older than that of inhabitants of Europe and the United States of America. The age of occurrence of varicella was consistently younger in patients than in controls. Of note is the fact that six patients had measles after the onset of MS. This study failed to incriminate any of the viruses tested in the aetiology of MS.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7241024      PMCID: PMC1052088          DOI: 10.1136/jech.34.4.258

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


  22 in total

1.  Measles antigen in multiple sclerosis: identification in the jejunum by immunofluorescence.

Authors:  L P Pertschuk; A W Cook; J Gupta
Journal:  Life Sci       Date:  1976-11-15       Impact factor: 5.037

2.  Virus antibody titers in multiple sclerosis patients, siblings, and controls.

Authors:  J A Brody; J L Sever; T E Henson
Journal:  JAMA       Date:  1971-05-31       Impact factor: 56.272

3.  Virus antibodies and multiple sclerosis.

Authors:  J L Sever; J F Kurtzke; M Alter; G A Schumacher; M R Gilkeson; J H Ellenberg; J A Brody
Journal:  Arch Neurol       Date:  1971-06

4.  Serological responses of multiple-sclerosis patients and controls to a virus isolated from a multiple-sclerosis case.

Authors:  G J Nemo; J A Brody; D J Waters
Journal:  Lancet       Date:  1974-11-02       Impact factor: 79.321

5.  Screening for asymptomatic urinary-tract infection in schoolgirls. A two-centre feasibility study.

Authors:  A W Asscher; M S McLachlan; R V Jones; S Meller; M Sussman; S Harrison; H H Johnston; G Sleight; E W Fletcher
Journal:  Lancet       Date:  1973-07-07       Impact factor: 79.321

6.  Fusion of cultured multiple-sclerosis brain cells with indicator cells: presence of nucleocapsids and virions and isolation of parainfluenza-type virus.

Authors:  V ter Meulen; H Koprowski; Y Iwasaki; Y M Käckell; D Müller
Journal:  Lancet       Date:  1972-07-01       Impact factor: 79.321

7.  Solid phase antibody assay by means of enzyme conjugated to anti-immunoglobulin.

Authors:  P Leinikki; S Pässilä
Journal:  J Clin Pathol       Date:  1976-12       Impact factor: 3.411

8.  Mixed lymphocyte culture determinants, measles infection and multiple sclerosis.

Authors:  P Platz; B Dupont; T Fog; L Ryder; M Thomsen; A Svejgaard; C Jersild
Journal:  Proc R Soc Med       Date:  1974-11

9.  Multiple sclerosis-associated agent: transmission to animals and some properties of the agent.

Authors:  U Koldovsky; P Koldovsky; G Henle; W Henle; R Ackermann; G Haase
Journal:  Infect Immun       Date:  1975-12       Impact factor: 3.441

10.  Decreased percentage of polymorphonuclear neutrophils in mouse peripheral blood after inoculation with material from multiple sclerosis patients.

Authors:  R I Carp; P C Licursi; P A Merz; G S Merz
Journal:  J Exp Med       Date:  1972-09-01       Impact factor: 14.307

View more
  11 in total

1.  Multiple sclerosis and Epstein-Barr virus.

Authors:  Ruth Ann Marrie; Christina Wolfson
Journal:  Can J Infect Dis       Date:  2002-03

2.  Multiple sclerosis in the Orkney and Shetland Islands and in north-east Scotland.

Authors: 
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-14

3.  Genome-wide homozygosity and multiple sclerosis in Orkney and Shetland Islanders.

Authors:  Rebekah E McWhirter; Ruth McQuillan; Elizabeth Visser; Carl Counsell; James F Wilson
Journal:  Eur J Hum Genet       Date:  2011-09-07       Impact factor: 4.246

4.  Multiple sclerosis in the Orkney and Shetland Islands. II: The search for an exogenous aetiology.

Authors:  D C Poskanzer; J L Sheridan; L B Prenney; A M Walker
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

5.  Multiple sclerosis in the Orkney and Shetland Islands. V: The effect on viral titres of histocompatibility determinants.

Authors:  D C Poskanzer; J L Sever; P I Terasaki; L B Prenney; J L Sheridan; M S Park
Journal:  J Epidemiol Community Health       Date:  1980-12       Impact factor: 3.710

6.  A population-based case-control study on viral infections and vaccinations and subsequent multiple sclerosis risk.

Authors:  Cecilia Ahlgren; Kjell Torén; Anders Odén; Oluf Andersen
Journal:  Eur J Epidemiol       Date:  2009-07-26       Impact factor: 8.082

7.  Epidemic measles in Shetland during 1977 and 1978.

Authors:  J D Macgregor; J MacDonald; E A Ingram; M McDonnell; B Marshall
Journal:  Br Med J (Clin Res Ed)       Date:  1981-02-07

8.  Risk factors in multiple sclerosis: a population-based case-control study in Hautes-Pyrénées, France.

Authors:  C Berr; J Puel; M Clanet; J B Ruidavets; J L Mas; A Alperovitch
Journal:  Acta Neurol Scand       Date:  1989-07       Impact factor: 3.209

9.  The environmental risk factors in multiple sclerosis susceptibility: A case-control study.

Authors:  Vahid Shaygannejad; Nooshin Rezaie; Zamzam Paknahad; Freshteh Ashtari; Helia Maghzi
Journal:  Adv Biomed Res       Date:  2016-06-08

Review 10.  Abnormalities of serum and plasma components in patients with multiple sclerosis.

Authors:  H C Ford
Journal:  Clin Biochem       Date:  1985-02       Impact factor: 3.281

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.